- Home
- BXMX vs TXG Comparison
BXMX vs TXG Comparison
Compare BXMX & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXMX
- TXG
- Stock Information
- Founded
- BXMX 2004
- TXG 2012
- Country
- BXMX United States
- TXG United States
- Employees
- BXMX N/A
- TXG N/A
- Industry
- BXMX Investment Managers
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- BXMX Finance
- TXG Industrials
- Exchange
- BXMX Nasdaq
- TXG Nasdaq
- Market Cap
- BXMX 1.5B
- TXG 1.7B
- IPO Year
- BXMX N/A
- TXG 2019
- Fundamental
- Price
- BXMX $14.04
- TXG $13.58
- Analyst Decision
- BXMX
- TXG Buy
- Analyst Count
- BXMX 0
- TXG 12
- Target Price
- BXMX N/A
- TXG $14.13
- AVG Volume (30 Days)
- BXMX 205.6K
- TXG 3.0M
- Earning Date
- BXMX 01-01-0001
- TXG 08-07-2025
- Dividend Yield
- BXMX 7.24%
- TXG N/A
- EPS Growth
- BXMX N/A
- TXG N/A
- EPS
- BXMX N/A
- TXG N/A
- Revenue
- BXMX N/A
- TXG $624,662,000.00
- Revenue This Year
- BXMX N/A
- TXG N/A
- Revenue Next Year
- BXMX N/A
- TXG $5.60
- P/E Ratio
- BXMX N/A
- TXG N/A
- Revenue Growth
- BXMX N/A
- TXG N/A
- 52 Week Low
- BXMX $11.75
- TXG $6.78
- 52 Week High
- BXMX $13.75
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- BXMX 62.81
- TXG 64.38
- Support Level
- BXMX $13.99
- TXG $11.45
- Resistance Level
- BXMX $14.18
- TXG $14.94
- Average True Range (ATR)
- BXMX 0.10
- TXG 0.79
- MACD
- BXMX -0.01
- TXG 0.07
- Stochastic Oscillator
- BXMX 69.14
- TXG 76.07
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).